【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spinal Cord Injury 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Spinal Cord Injury Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Spinal Cord Injury 34
May 19, 2014: StemCells Provides Update on Its Phase I/II Study in Spinal Cord Injury 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Acorda Therapeutics, Inc. 36
Clinical Trial Overview of Acorda Therapeutics, Inc. 36
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Stem Cell Sciences UK Ltd 38
Clinical Trial Overview of Stem Cell Sciences UK Ltd 38
Neuralstem, Inc. 39
Clinical Trial Overview of Neuralstem, Inc. 39
BioAxone BioSciences Inc. 40
Clinical Trial Overview of BioAxone BioSciences Inc. 40
AOSpine International 41
Clinical Trial Overview of AOSpine International 41
K-Stemcell Co., Ltd. 42
Clinical Trial Overview of K-Stemcell Co., Ltd. 42
Daiichi Sankyo Company, Limited 43
Clinical Trial Overview of Daiichi Sankyo Company, Limited 43
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Clinical Trial Overview of Top Institutes / Government 45
U.S. Department of Veterans Affairs 45
Clinical Trial Overview of U.S. Department of Veterans Affairs 45
University of Miami 48
Clinical Trial Overview of University of Miami 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
National Institute of Neurological Disorders and Stroke 50
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 50
University of British Columbia 51
Clinical Trial Overview of University of British Columbia 51
Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
China Spinal Cord Injury Network 53
Clinical Trial Overview of China Spinal Cord Injury Network 53
National Taiwan University Hospital 54
Clinical Trial Overview of National Taiwan University Hospital 54
James J. Peters Veterans Affairs Medical Center 55
Clinical Trial Overview of James J. Peters Veterans Affairs Medical Center 55
University of California, Irvine 56
Clinical Trial Overview of University of California, Irvine 56
Five Key Clinical Profiles 57
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106
【レポート販売概要】
■ タイトル：脊髄損傷治療のグローバル臨床試験動向（2014年下半期）■ 英文：Spinal Cord Injury Global Clinical Trials Review, H2, 2014
■ 発行日：2014年7月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC2282CTIDB
■ 調査対象地域：グローバル
- 世界のメチルエチルケトン(MEK)市場2015The Global Methyl Ethyl Ketone (MEK) Industry Report 2015 is a professional and in-depth study on the current state of the Methyl Ethyl Ketone (MEK) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Methyl Ethyl Ketone (MEK) market analysis is provided for the international markets including developm …
- マシンビジョンの世界市場：ビジョンシステム、カメラAbout Machine Vision Machine vision technology helps analyze and inspect images through various machine vision software, hardware, and accessories. It includes four processes: guidance, identification, measurement, and inspection. The machine vision technology captures an image, transfers it to processor systems for inspection, and reports the processed results. Machine vision products have been u …
- M2Mサービスの世界市場2017-2021About Machine-to-Machine M2M ServicesA machine-to-machine (M2M) platform is a programmed unit in which M2M applications and services are built on. Owing to the growing adoption of the Internet of Things (IoT) and M2M services, the demand for innovative M2M platforms to enable new M2M services (such as connected cars and smart homes) is increasing. Also, many small players are entering the global M …
- 世界の農業用殺虫剤市場（～2019）The global insecticides market is flourishing due to the increasing pressure of meeting the food requirement of the ever-increasing population and the reducing size of arable land. Farmers want to reduce their losses in order to increase crop yield and increase profitability. Insecticides help to kill and inhibit the growth of insects that adversely affect crops, while being totally harmless to no …
- D‐リボースの世界市場D-ribose (CAS 50-69-1) Market Research Report 2014 presents comprehensive data on d-ribose markets globally and regionally (Europe, Asia, North America etc.) The report includes d-ribose description, covers its application areas and related patterns. It overviews d-ribose market, names d-ribose producers and indicates its suppliers. Besides, the report provides d-ribose prices in regional markets. …
- 2014年戦略提言：スペインの核酸検査市場Highlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends …
- 世界のCRBN（化学・生物・放射性物質・核）防衛市場動向2013-2023：市場のSWOT分析This SWOT analysis of CBRN market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global CBRN Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI strictly follows a standardized rese …
- 世界における小型自動車用燃料タンク市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE fuel tanks sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE fuel tanks market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects …
- 世界のインテリジェントプリント管理（IPM）市場動向（2012-2016）TechNavio's analysts forecast the Global Intelligent Print Management market to grow at a CAGR of 6.70 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for significant cost reduction. The Global Intelligent Print Management market has also been witnessing the increasing adoption of cloud and mobile printing. However, the increasing security c …
- 無人機用繊維強化ポリマの世界市場The unmanned systems composite market is estimated to be valued at $5.22 billion in 2015and is projected to grow at a CAGR of 8.26% to reach $7.76 billion by 2020 This report provides an analysis of the unmanned systems composite market during the forecast period (2015-2020). It provides the analysis of drivers, challenges, restraints, and burning issues that impact the industry. It also discusses …
- 海底ポンプのグローバル市場（～2018）This report estimates the subsea pumps market in terms of value. The value market is estimated in terms of number of subsea processing projects being already and the upcoming per year and value in terms of contract value. This has been broken down into regions, type of pumps and is also split into subsea applications. Subsea pumps are required for oil and gas development. The ever-increasing offsh …
- グローバル及び地域メガトレンド：「トラスト（信頼）」における消費者態度及び行動の理解Summary “Global and Regional Mega-Trends: Understanding Consumer Attitudes and Behaviors in Trust' examines how and why people are becoming less trusting of the practices and activities of brands and corporations. The report focuses on how traceability is more important than ever when it comes to protecting brand share and what strategies brands can engage to maximise perceptions of trust over the …
- DeeThree Exploration Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013DeeThree Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary DeeThree Exploration Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
- 末梢神経鞘腫瘍(神経線維肉腫)：グローバル臨床試験レビュー（2014年上半期）Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014" provides data on the Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trial scenario. This report provides elemental information and data relating to the clinical t …
- 3Dバイオプリンティングの世界市場2015-2022According to Stratistics MRC, the 3D bioprinting market is projected to reach $6,120 million by 2022 growing at a CAGR of 17.4% from 2015 to 2022. Incorporation of IT within the healthcare industry is the key driving factor for the growth of 3D bioprinting market. Rapidly increasing aging population, rising incidence of chronic illnesses, huge investment in R & D, growing demand for organ and tiss …
